Top Story

Allergan responds to Valeant, Pershing Square counterclaims

September 2, 2014

Allergan has filed an answer in the U.S. District Court for the Central District of California in response to Valeant Pharmaceuticals and Pershing Square Capital Management counterclaims, according to an Allergan press release.

The response addresses counterclaims from Valeant and Pershing Square regarding Allergan’s previous statements on the unsustainability of Valeant’s underlying business model, according to the release.

Breaking News

Ozurdex approved in EU for treatment of DME

September 2, 2014
The European Commission has extended marketing authorization for Ozurdex for the treatment of diabetic macular edema in certain patients, according to an Allergan press…
figure The Dry EyePublication Exclusive

Dry eye specialists should be on the lookout for ‘zebras’ in the summer

September 2, 2014
It is summertime in the northern latitudes, and all is well in the dry eye clinics of North America. Remember how hard it was to be a dry eye doc last winter during the…

To move forward and reach your potential, never stop learning

September 1, 2014
The 90s called; they want their refractive surgery back. Likewise, the turn of the millennium called and wants its cataract surgery back. Our world is changing…
More News Headlines »

Managing associate optometrists in your practice, part 4

July 31, 2014
As with eye surgeons, not all optometrists are created equally. It’s a broad but true generalization that younger…
More »
Meeting News Coverage Video

Speaker discusses HOME study

August 13, 2014
At the American Society of Retina Specialists meeting in San Diego, David S. Boyer, MD, discusses results from the HOME…
More »